Pathway analysis revealed that genes deregulated between GPC1-low and GPC1-high patients are associated with pathways involved in immunological aspects of cancer progression and metastatic dissemination including activation of neutrophil extracellular trap signaling pathway and inhibition of pathogen induced cytokine storm signaling pathway as well as IL-4 signaling (Figure 7A). The gene discussed is GPC1; the disease is cancer.